NCT00287014

Completed

Rift Valley Fever in Kenya

National Institute of Allergy and Infectious Diseases (NIAID)Source

Compare

Other study identifiers

Sponsor study identifier

05-0042

Study Type

observational

Reported enrollment (type unavailable)

250

Locations

1 country

Sites

1

Timeline

Study Start

March 2006

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

April 2006

Date type not reported

This date has not been verified as actual or estimated.

Brief Summary

The purpose of this study is to find out how, why, and when Rift Valley Fever (RVF) spreads. Participants will be 250 adults and children, aged 1 year and older, from the Ijara District, Kenya. They will be given a questionnaire, undergo a medical examination that includes an eye exam, and have a 1-teaspoon sample of blood taken from a vein. Participation will take about 3 hours.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Reported enrollment (type unavailable): 250 participants
Study completion date: April 2006
Date type not reported
This date has not been verified as actual or estimated.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
February 2, 2006
Actual (reported)
First Posted
February 6, 2006
Actual (reported)
Study Start
March 2006
Date type not reported
This date has not been verified as actual or estimated.
Study Completion
April 2006
Date type not reported
This date has not been verified as actual or estimated.

Last Updated: August 27, 2010
Status Verified: October 2007
Last Update Submitted: August 26, 2010

Conditions

Rift Valley Fever

Keywords

Rift valley fever, Kenya

Eligibility Criteria

Age1 Year+

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

Those adults and children residing in selected survey households in the area of Ijara Town and its 5 km environs who are 1 year of age and older will be eligible, provided:
Informed consent is obtained and signed, and assent form is obtained and signed from children age 7 and older,
Subject has understanding of study procedures, and
Subject is able to comply with study procedures for the entire length of the study.

You may not qualify if:

Sponsors & Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)
NIHlead

Study Sites (1)

Ijara District

Ijara, Kenya

MeSH Terms

Conditions

Rift Valley Fever

Condition Hierarchy (Ancestors)

Hepatitis, Viral, AnimalHepatitis, AnimalInfectionsMosquito-Borne DiseasesVector Borne DiseasesArbovirus InfectionsVirus DiseasesBunyaviridae InfectionsRNA Virus InfectionsHemorrhagic Fevers, ViralHepatitisLiver DiseasesDigestive System DiseasesAnimal Diseases

Study Design

Study Type: observational
Time Perspective: PROSPECTIVE
Sponsor Type: NIH

Study Record Dates

First Submitted

February 2, 2006

First Posted

February 6, 2006

Study Start

March 2006

Date type not reported

This date has not been verified as actual or estimated.

Study Completion

April 2006

Date type not reported

This date has not been verified as actual or estimated.

NCT06799234

Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)

Phase 2Active Not Recruiting

NCT04754776

Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)

Early Phase 1Completed

NCT06925919

Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011

Phase 1Active Not Recruiting

NCT04672824

A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults

Phase 1Completed

NCT05139524

RVF and Other Emerging Infectious Diseases in East and Central Africa

Recruiting

Age less than 1 year.

Subjects who immigrated to the study area less than 2 years previously.

Acutely ill Ijara residents.

Adults and children who cannot provide informed consent or who cannot participate fully in the study procedures will also be excluded.

Contact the study team to confirm eligibility.

Last Updated

August 27, 2010

Record last verified: 2007-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00287014
Data provider: ClinicalTrials.gov
Source updated: 2010-08-27
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:25:19 UTC

Locations

KE(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

Source record

Locations